8 assets in Intestinal Neoplasm

Therapeutic assets addressing Intestinal Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Intestinal Neoplasm	Pfizer	P3	BB (67)
Fluorouracilum Intestinal Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P3	BB (66)
Capecitabine Intestinal Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P3	BB (65)
Oxaliplatin Intestinal Neoplasm	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P3	B (62)
pf-08634404 Intestinal Neoplasm	Pfizer	P3	B (60)
Sgm-101 Intestinal Neoplasm	Leiden University Medical Center	P2	CCC (53)
Trastuzumab Intestinal Neoplasm	Fudan University	P2	CCC (53)